
Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3
Keywords: Schisandrin B; STAT3; Apoptosis; Triple negative breast cancer; Bax; Bcl-2 associated protein x; Bcl-2; B-cell lymphoma 2; Bcl-xl; B-cell lymphoma-extra large; CDC2; cell division cycle 2; DAPI; 4, 6diamidino-2-phenylindole; DMSO; dimethylsulfoxide; FITC;